Company's goal is to be able to produce one million doses of Escozine per month in the near term. As the Company furthers its clinical trials and nutraceutical sales of Escozine, it anticipates that demand will increase exponentially. As such, it has worked with the Ministry of Environment in the DR to secure the appropriate licensing and approvals for the expansion of the reservation and the building of the lab facility.